6 articles filed here
The EU has pushed back its high-risk AI rules to December 2027 while the US fights over whether federal orders can override state AI laws. We explain what changed, what still applies now, and what it means for researchers.
The US still has no federal AI law. We map how state AI laws now govern health AI, from chatbot crisis rules to human review of insurance denials, and what federal preemption could change.
The EU AI Act's next deadline lands on 2 December 2026. We explain what it means for AI in drug discovery, which rules the Digital Omnibus delayed, and where the real compliance work for AI-designed drugs sits.
AI can now write working virus genomes. Who is responsible for checking them? A plain-English tour of AI biosecurity rules in the US, EU, UK and beyond.
The EU's science service studied 480 biological AI models and found a gap between scientific brilliance and real-world readiness. Here's what the JRC report says and why it matters.
August 2, 2026 was supposed to be the day the EU AI Act's toughest rules hit high-risk systems. Then the Digital Omnibus moved the goalposts. Here's what actually changed, and what it means for AI in drug discovery.
